Business Wire

Berlin’s First Smart City Quarter Powered by Panasonic

1.7.2020 13:00:00 EEST | Business Wire | Press release

Share

Panasonic is proud to announce the start of its innovative, CO2-saving energy solution for the smart city project, Future Living® Berlin. The urban beacon is an important project in the company’s wider smart cities portfolio, which contribute to its focus on the decarbonization of society.

The installation in Berlin combines both green & sustainable and digital & connected living. It is realised through the installation of smart energy solutions including Panasonic’s highly efficient air to water heat pumps, photovoltaic (PV) panels and storage batteries integrated into an intelligent and efficient energy management system.

Junichi Suzuki, Chairman and CEO of Panasonic Europe B.V comments,

‘We bring to the project over 60 years of heating and cooling expertise alongside decades in PV and battery solutions, and a passion for innovations that will shape the future for generations to come. ‘

Panasonic has achieved strong sales growth in the relevant Energy business areas in Europe, e.g. double-digit sales growth in the air to water heat pump business for the last 10 years. The company has also committed in 2019 to grow the “Residential Energy Saving Equipment” business multiple times over by 2025.

Efficient Energy Management

For Panasonic, Future Living® Berlin is a fundamentally important experiment in building cutting-edge energy solutions. The project marks a milestone in achieving the goals set in the strategy.

Panasonic’s energy experts and software engineers of its R&D Centre in Europe have developed an intelligent energy management solution to optimize the use of energy and couple electricity with the heating sector. The smart control combines heat pumps together with other efficient, green Panasonic technologies, such as PV panels. The technologies have been integrated into an efficient energy saving solution not only controlled, but also constantly optimised by Panasonic’s intelligent energy management solution.

Ralf Becker, Project Leader Energy Group, Panasonic R&D Centre Europe explains,

‘The solution is a world first, developed with leading research institutions for decentralized energy management. In simulations together with university test labs we achieved an improvement of used energy by up to 15%.‘

A Beacon for Sustainable Living

The core energy component of the Future Living Berlin green & sustainable goal is the installed Panasonic’s air to water heat pump product line-up, ‘Aquarea’. A highly energy efficient technology, they run almost carbon-free when powered by the renewable energy provided by the 600 Panasonic HIT panels, which supply a capacity of 195kWp. On account of the patented silicone technology, the Panasonic photovoltaic system is 10% more efficient than conventional modules. Furthermore Panasonic’s HIT technology achieves a significantly better performance in hot environments because of its superior temperature coefficient – an essential advantage in coping with the climate change.

Utilising the renewable energy, the air to water system is used for space heating and warm water generation. For increased performance, the heat pumps include a cloud-based connectivity feature for installers called Aquarea Service Cloud which makes them even more reliable. It saves further CO2 emissions as maintenance visits can be organized much more efficiently and partly even conducted remotely.

These energy solutions are brought together under a Aquarea Smart Cloud, which allows end-users to monitor their power usage and manage temperature settings accordingly. This results in increased efficiency and comfort while enjoying transparency of their consumption.

To achieve further sustainable and green objectives, residents are part of a wider ecological environment which offers green car sharing, shared washing machines, and Panasonic energy solutions

Connected comfortability

The digital & connected goal of Future Living Berlin starts within the residential apartments. The equipment follows the idea of being smart and connected with Panasonic TVs and smart speakers being part of an overall IoT infrastructure, which includes an apartment manager as the central hub.

Digital & connected solutions are further extended to include wider security, safety, and smart building solutions that enhance the overall comfortability of residents.

Suzuki continues,

‘Future Living® Berlin is a future Way of Living – of how we may live tomorrow with a focus on social, digital & connected, and green & sustainable living.’

Panasonic is partnering in the smart city project with GSW Sigmaringen, the building-owner of Future Living® Berlin.

About Panasonic

Panasonic Corporation is a global leader developing innovative technologies and solutions for wide-ranging applications in the consumer electronics, housing, automotive, and B2B sectors. The company, which celebrated its 100th anniversary in 2018, operates 528 subsidiaries and 72 associated companies worldwide and reported consolidated net sales of 61.9 billion Euro (7.49 trillion yen) for the year ended March 31, 2020. Committed to pursuing new value through collaborative innovation, the company uses its technologies to create a better life and a better world for customers. To learn more about Panasonic: https://www.panasonic.com/global

IMAGES TO DOWNLOAD: https://www.flickr.com/photos/panasonic-europe/collections/72157714840244853/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Tanya Houston
Wildwood PR Ltd
tanya.houston@wildwoodpr.com
Tel: +44 (0)1293 851115

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Merz Therapeutics Presents New Phase 2 PaiNT Data in Peripheral Neuropathic Pain at IASP 202626.10.2026 09:00:00 EET | Press release

Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced the presentation of new clinical and translational research in peripheral neuropathic pain (PNP) at the International Association for the Study of Pain (IASP) 2026 World Congress in Bangkok, Thailand, taking place from 26 to 30 October. The research spans new Phase 2 findings on incobotulinumtoxinA in postherpetic neuralgia (PHN) and post-surgical/post-traumatic neuropathic pain (PS/PTNP), as well as preclinical studies exploring potential biological mechanisms involved in effects of incobotulinumtoxinA on PNP models, highlighting Merz Therapeutics’ growing presence in neuropathic pain. In the PHN population of the Phase 2 PaiNT trial, results over 20 weeks favored incobotulinumtoxinA versus placebo treatment. In an exploratory analysis of average daily pain (ADP) intensity, the greatest difference between treatment groups was observed at Week 6 (adjusted mean difference, −1.14 points; p=0.0488).

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye